ArticleAsian Pacific journal of cancer prevention : APJCP2025
Exploring the Therapeutic Potential of Oxo berberine Compound in Arcangelisia flava Root Extract for Breast Cancer Treatment: Metabolite Profiling, Pharmacological Network Analysis, and In Silico and In Vitro Evaluation.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integrative analysis and in vitro assessment of the effects of α-mangostin on high-glucose-induced inflammatory and oxidative stress responses in RAW264.7 macrophages.BMC complementary medicine and therapies · 2026Article
- A Network Pharmacology Review of Plant-Derived Anticancer Compounds in Lung, Breast, Colorectal and Prostate Cancer.International journal of molecular sciences · 2026Review
- Berberine in breast cancer, a multi-targeted therapeutic agent from mechanisms to clinical translation.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveChemotherapy treatments for breast cancer often entail side effects and drug resistance. Arcangelisia flava root extract (AFRE) shows potential as an anti-cancer agent, but understanding its compounds and mechanisms against breast cancer remains limited. This study aims to identify potential compounds in AFRE and shed light on its actions against breast cancer.
methodsCompounds in AFRE were identified via LC-MS/MS. ADMET software evaluated absorption and bioavailability. Molecular anti-cancer mechanisms were predicted using network pharmacology with tools like Cytoscape, GeneCards, Disgenet, STRING, GO, KEGG pathways, and SRplot. Interaction between oxo berberine and key breast cancer receptors was analyzed through molecular docking with PyRx Autodock Vina and Biovia Discovery Studio. Cytotoxicity was assessed using the MTT method on T47D cells, and flow cytometry evaluated the potential to inhibit the cell cycle and induce apoptosis.
resultA total of 16 active compounds were identified through LC-MS/MS, with oxo berberine being the most abundant at 41.43%. Importantly, it exhibited anti-cancer properties by interacting with 84 genes and affecting 13 signaling pathways related to breast cancer. We found that oxo berberine had a stronger negative binding affinity with PI3KCA, TP53, BCL2, CDK1, EGFR, and MAPK14 than the native ligand, which was supported by molecular docking results. In vitro validation supported these results even more, showing that AFRE treatment caused more T47D cells to die (36.6%) than the control and doxorubicin, as well as more cells to gather in the G1 phase.
conclusionIn summary, this evidence highlights the potent anti-cancer effects of oxo berberine in AFRE against breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.